The Patent Finder

Rijksuniversiteit Groningen

24 patents currently held · Updated Nov 18, 2026
11 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 7 name spellings.

0
Ending by 2030
Oct 2032
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Mar 26, 2027
    The maintenance fee for Biomaterial substrates, cell culture systems comprising the same and uses thereof in cell screening applications (US 11,767,505) comes due Mar 26, 2027. Unpaid by Sep 27, 2027, it lapses early.
  • 1 fee due Jun 19, 2027
    The maintenance fee for Arginase inhibitors (US 11,845,767) comes due Jun 19, 2027. Unpaid by Dec 20, 2027, it lapses early.
  • 1 fee due Aug 18, 2027
    The maintenance fee for Breath actuated dry powder inhaler (US 10,561,809) comes due Aug 18, 2027. Unpaid by Feb 18, 2028, it lapses early.
  • 1 fee due Oct 23, 2027
    The maintenance fee for Method, System and Computer Program Product for Mapping a Visual Field (US 11,966,511) comes due Oct 23, 2027. Unpaid by Apr 24, 2028, it lapses early.
  • 1 fee due Nov 14, 2027
    The maintenance fee for Photoresponsive nutlin derivatives and uses thereof (US 11,981,664) comes due Nov 14, 2027. Unpaid by May 15, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 2 of the patents on this record were granted since Aug 20, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 9,657,322Glucooligosaccharides comprising (alpha 1->4) and (alpha 1->6) glycosidic bonds, use thereof, and methods for providing them
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,944,694Antibodies against Staphylococcus aureus and uses therof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,268,151Biomarkers for cervical cancer
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,731,195Methods for the enzymatic modification of steviol glycosides, modified steviol glycosides obtainable thereby, and the use thereof as sweeteners
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,396,665A CRISPR-Cas System for a Filamentous Fungal Host Cell
In force
 · High confidence
In forceHigh confidence
US 10,561,809Breath actuated dry powder inhaler
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,169,138Nanopores with Internal Protein Adaptors
In force
 · High confidence
In forceHigh confidence
US 11,280,802Methods and kits for the derivatization of a biogenic amine
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,312,755Biological Nanopores for Biopolymer Sensing and Sequencing Based on FRAC Actinoporin
In force
 · High confidence
In forceHigh confidence
US 11,202,634Instrument for performing anastomosis
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 24 patents shown.
Pro members see all 24.
Pro members: see all 24 patents
Also on record, not counted in the 24: 11 patents in force now held by others · 28 lapsed for an unpaid fee · 30 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

16 pending · 11 abandoned · 39 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited